SG11202008182TA - Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor - Google Patents
Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses thereforInfo
- Publication number
- SG11202008182TA SG11202008182TA SG11202008182TA SG11202008182TA SG11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA
- Authority
- SG
- Singapore
- Prior art keywords
- aav
- vectors
- associated virus
- uses therefor
- novel adeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635964P | 2018-02-27 | 2018-02-27 | |
| US201862677471P | 2018-05-29 | 2018-05-29 | |
| US201862667585P | 2018-05-29 | 2018-05-29 | |
| US201862703670P | 2018-07-26 | 2018-07-26 | |
| US201862722382P | 2018-08-24 | 2018-08-24 | |
| PCT/US2019/019804 WO2019168961A1 (fr) | 2018-02-27 | 2019-02-27 | Nouveaux vecteurs de virus adéno-associés (vaa), vecteurs de vaa présentant une désamidation de capside réduite et utilisations associées |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202008182TA true SG11202008182TA (en) | 2020-09-29 |
Family
ID=67805569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202008182TA SG11202008182TA (en) | 2018-02-27 | 2019-02-27 | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200407750A1 (fr) |
| EP (1) | EP3758724A4 (fr) |
| JP (3) | JP2021516046A (fr) |
| KR (1) | KR20210010434A (fr) |
| CN (1) | CN112352050A (fr) |
| AU (1) | AU2019227726A1 (fr) |
| BR (1) | BR112020017348A2 (fr) |
| CA (1) | CA3091806A1 (fr) |
| CL (2) | CL2020002200A1 (fr) |
| IL (1) | IL276859A (fr) |
| MX (1) | MX2020008933A (fr) |
| SG (1) | SG11202008182TA (fr) |
| WO (1) | WO2019168961A1 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2996420A1 (fr) | 2015-09-28 | 2017-04-06 | The University Of North Carolina At Chapel Hill | Procedes et compositions pour vecteurs viraux evitant les anticorps |
| JP7406677B2 (ja) | 2018-04-03 | 2023-12-28 | ギンコ バイオワークス インコーポレイテッド | 抗体を回避するウイルスベクター |
| TW202102525A (zh) | 2019-03-21 | 2021-01-16 | 美商史崔德生物公司 | 重組腺相關病毒載體 |
| EP4038194A1 (fr) | 2019-10-04 | 2022-08-10 | Ultragenyx Pharmaceutical Inc. | Procédés pour une utilisation thérapeutique améliorée d'aav recombinant |
| TW202128736A (zh) | 2019-10-17 | 2021-08-01 | 美商史崔德生物公司 | 用於治療ｃ型尼曼—匹克病之腺相關病毒載體 |
| US20230002788A1 (en) * | 2019-10-21 | 2023-01-05 | The Trustees Of The University Of Pennsylvania | Aav3b variants with improved production yield and liver tropism |
| WO2021138381A1 (fr) * | 2020-01-03 | 2021-07-08 | Sarepta Therapeutics, Inc. | Procédés d'analyse de protéines de capside vaa |
| AU2021218703A1 (en) * | 2020-02-14 | 2022-07-28 | Ultragenyx Pharmaceutical Inc. | Gene therapy for treating CDKL5 deficiency disorder |
| WO2021202532A1 (fr) | 2020-03-31 | 2021-10-07 | Ultragenyx Pharmaceutical Inc. | Thérapie génique pour le traitement de l'acidémie propionique |
| AU2021292200A1 (en) | 2020-06-17 | 2023-02-02 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treatment of gene therapy patients |
| KR20230038503A (ko) | 2020-07-13 | 2023-03-20 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 샤르코-마리-투스 질환의 치료에 유용한 조성물 |
| AR123838A1 (es) * | 2020-10-18 | 2023-01-18 | Univ Pennsylvania | Vector mejorado de virus adenoasociado (aav) y usos de este |
| WO2022094180A1 (fr) * | 2020-10-29 | 2022-05-05 | The Trustees Of The University Of Pennsylvania | Capsides de vaa et compositions les contenant |
| US20240024507A1 (en) | 2020-12-01 | 2024-01-25 | The Trustees Of The University Of Pennsylvania | Novel compositions with tissue-specific targeting motifs and compositions containing same |
| BR112023015303A2 (pt) | 2021-02-01 | 2023-11-14 | Regenxbio Inc | Método para tratar doença cln2 devido a deficiência de tpp1 em um sujeito |
| AU2022258312A1 (en) | 2021-04-12 | 2023-10-26 | The Trustees Of The University Of Pennsylvania | Compositions useful for treating spinal and bulbar muscular atrophy (sbma) |
| MX2023012513A (es) | 2021-04-23 | 2023-12-15 | Univ Pennsylvania | Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen. |
| CN116444626A (zh) * | 2021-12-28 | 2023-07-18 | 成都弘基生物科技有限公司 | 经过修饰的aav衣壳蛋白及其用途 |
| WO2023133584A1 (fr) | 2022-01-10 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions utiles dans le traitement d'une leucodystrophie métachromatique |
| WO2023133574A1 (fr) | 2022-01-10 | 2023-07-13 | The Trustees Of The University Of Pennsylvania | Compositions et méthodes utiles pour le traitement de troubles médiés par c9orf72 |
| WO2023147304A1 (fr) | 2022-01-25 | 2023-08-03 | The Trustees Of The University Of Pennsylvania | Capsides d'aav pour une transduction cardiaque améliorée et un ciblage du foie |
| TW202342740A (zh) | 2022-03-07 | 2023-11-01 | 美商奧崔基尼克斯製藥公司 | 改良的批量aav生產系統和方法 |
| WO2023196892A1 (fr) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Immunisation passive avec des anticorps neutralisants anti-aav pour empêcher la transduction hors cible de vecteurs aav administrés par voie intrathécale |
| CN115011601B (zh) * | 2022-06-27 | 2023-07-21 | 山东大学齐鲁医院 | 一种干扰JUND表达的shRNA、重组腺相关病毒载体及其应用 |
| WO2024015966A2 (fr) * | 2022-07-15 | 2024-01-18 | The Trustees Of The University Of Pennsylvania | Vaa recombinants ayant des capsides de clade d et de clade e de vaa et compositions les contenant |
| WO2024130070A2 (fr) | 2022-12-17 | 2024-06-20 | The Trustees Of The University Of Pennsylvania | Capsides aav recombinantes avec motifs de ciblage spécifiques du muscle cardiaque et squelettique et leurs utilisations |
| WO2024130067A2 (fr) | 2022-12-17 | 2024-06-20 | The Trustees Of The University Of Pennsylvania | Vecteurs mutants aav recombinants avec motifs de ciblage spécifiques des muscles cardiaque et squelettique et compositions les contenant |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298926A1 (fr) * | 2003-09-30 | 2011-03-23 | The Trustees of The University of Pennsylvania | Clades (sous-types) et séquences de Virus Adeno-Associé (AAV), vecteurs les contenant et leurs utilistation |
| EP3409296A1 (fr) * | 2005-04-07 | 2018-12-05 | The Trustees of the University of Pennsylvania | Procédé d'amélioration de la fonction d'un vecteur aav |
| RU2683497C2 (ru) * | 2012-04-18 | 2019-03-28 | Дзе Чилдрен'З Хоспитал Оф Филадельфия | Композиция и способы высокоэффективного переноса генов с помощью вариантов капсида aav |
| SG10201809075XA (en) * | 2013-07-22 | 2018-11-29 | Childrens Hospital Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| US11015173B2 (en) * | 2015-12-11 | 2021-05-25 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAV1 |
| CA3019423A1 (fr) * | 2016-04-15 | 2017-10-19 | The Trustees Of The University Of Pennsylvania | Nouvelles capsides mutantes de aav8 et compositions les contenant |
| TN2019000047A1 (en) * | 2016-08-15 | 2020-07-15 | Genzyme Corp | Methods for detecting aav |
| SG11201907714UA (en) * | 2017-02-28 | 2019-09-27 | Univ Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
-
2019
- 2019-02-27 WO PCT/US2019/019804 patent/WO2019168961A1/fr unknown
- 2019-02-27 EP EP19760264.2A patent/EP3758724A4/fr active Pending
- 2019-02-27 KR KR1020207027457A patent/KR20210010434A/ko active Search and Examination
- 2019-02-27 US US16/975,541 patent/US20200407750A1/en active Pending
- 2019-02-27 CA CA3091806A patent/CA3091806A1/fr active Pending
- 2019-02-27 AU AU2019227726A patent/AU2019227726A1/en active Pending
- 2019-02-27 JP JP2020545160A patent/JP2021516046A/ja active Pending
- 2019-02-27 CN CN201980028806.2A patent/CN112352050A/zh active Pending
- 2019-02-27 BR BR112020017348-7A patent/BR112020017348A2/pt unknown
- 2019-02-27 MX MX2020008933A patent/MX2020008933A/es unknown
- 2019-02-27 SG SG11202008182TA patent/SG11202008182TA/en unknown
-
2020
- 2020-08-23 IL IL276859A patent/IL276859A/en unknown
- 2020-08-26 CL CL2020002200A patent/CL2020002200A1/es unknown
-
2022
- 2022-12-26 CL CL2022003757A patent/CL2022003757A1/es unknown
-
2023
- 2023-08-14 JP JP2023131761A patent/JP2023159235A/ja active Pending
-
2024
- 2024-01-18 JP JP2024005924A patent/JP2024041967A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020008933A (es) | 2021-01-15 |
| EP3758724A4 (fr) | 2022-07-06 |
| AU2019227726A1 (en) | 2020-09-10 |
| IL276859A (en) | 2020-10-29 |
| BR112020017348A2 (pt) | 2020-12-29 |
| CA3091806A1 (fr) | 2019-09-06 |
| EP3758724A1 (fr) | 2021-01-06 |
| JP2024041967A (ja) | 2024-03-27 |
| CN112352050A (zh) | 2021-02-09 |
| JP2023159235A (ja) | 2023-10-31 |
| KR20210010434A (ko) | 2021-01-27 |
| JP2021516046A (ja) | 2021-07-01 |
| US20200407750A1 (en) | 2020-12-31 |
| CL2022003757A1 (es) | 2023-05-19 |
| CL2020002200A1 (es) | 2021-01-29 |
| WO2019168961A1 (fr) | 2019-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276859A (en) | Novel adeno-associated virus (AAV) vectors, AAV vectors with reduced capsid deamidation and uses thereof | |
| IL276860A (en) | Novel adeno-associated virus (AAV) vectors, AAV vectors with reduced capsid deamidation and uses thereof | |
| IL286911A (en) | Recombinant adeno-associated viruses and their uses | |
| ZA201905407B (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
| IL286464A (en) | A virus of vectors related to recombinant DNA | |
| IL282885A (en) | AAV viral vectors and their uses | |
| IL263801B1 (en) | Novel adeno-associated virus capsid proteins | |
| IL286926A (en) | Recombinant adeno-associated virus serotype modified peptide between aav9 and aavrh74 with reduced liver tropism and increased muscle transduction | |
| EP3368054A4 (fr) | Expression régulable au moyen d'un virus adéno-associé (vaa) | |
| ZA201801657B (en) | Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same | |
| EP3262162A4 (fr) | Expression régulable au moyen du virus adéno-associé (vaa) | |
| TR201901582T4 (tr) | Kapsid | |
| EP4303225A3 (fr) | Vecteurs viraux adéno-associés polyploïdes et leurs procédés de fabrication et d'utilisation | |
| CA2921232A1 (fr) | Vecteurs du facteur viii de virus associe aux adenovirus | |
| IL287214A (en) | Adeno-associated virus vector formulations and methods | |
| EP3575398A4 (fr) | Mutant de protéine de capside de virus adéno-associé (vaa) | |
| IL286831A (en) | An adeno-associated virus with an engineered capsid | |
| IL286725A (en) | Transgenic adeno-associated vectors for transgene expression | |
| IL289489A (en) | A chemically modified adeno-associated virus | |
| EP3956439A4 (fr) | Virus de la peste porcine classique recombiné | |
| IL287614A (en) | Adeno-associated virus (aav) particles modified for gene therapy | |
| SG11201704919SA (en) | Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) | |
| IL285639A (en) | Adeno-associated virus vectors for drug delivery | |
| EP3733855A4 (fr) | Vecteur de virus adéno-associé (vaa) comprenant un gène hgf hybride introduit en son sein | |
| AU2019902377A0 (en) | AAV capsid polypeptides and AAV vectors |